You are here

Kaletra

Large UK study finds no benefit to HIV antiviral in COVID-19

BioPharma Dive

Tue, 06/30/20 - 11:31 pm

After Kaletra setback, AbbVie joins forces with biotech, academia for experimental COVID-19 hopeful

Fierce Biotech

Fri, 06/5/20 - 10:37 am

Erasmus Medical Center

Utrecht University

HIV And Flu Drugs Prove Futile In Fight Against Coronavirus

Forbes

Tue, 04/21/20 - 11:51 pm

clinical trials

AbbVie gives up patent rights to HIV med Kaletra amid COVID-19 tests: report

Fierce Pharma

Mon, 03/23/20 - 11:37 pm

AbbVie will allow generic copies of its HIV pill in Israel after the government approved a license

Stat

Sat, 03/21/20 - 12:05 am

First clinical data show biopharma the way against Covid-19

EP Vantage

Fri, 03/20/20 - 10:11 am

New data from randomized trial dent HIV drug strategy against Covid-19

Endpoints

Thu, 03/19/20 - 10:55 am

clinical trials

AbbVie to Test HIV Drug as a Potential Coronavirus Treatment

Motley Fool

Tue, 03/10/20 - 11:03 am

Abbott's Pipeline Is Crucial In Advance Of 2016 Patent Cliff

Forbes

Wed, 05/30/12 - 03:03 pm

Abbott Laboratories

Abbott’s Kaletra Tied to Risks in Premature Babies, FDA Says

Bloomberg

Tue, 03/8/11 - 11:32 am

Abbott Tells Jurors Kaletra Was ‘Clobbered’ by Competitors

Bloomberg

Tue, 03/1/11 - 02:28 pm

Abbott Laboratories

India Rejects Patent Application for Abbott’s Kaletra

Bloomberg

Tue, 01/4/11 - 10:08 am

Abbott Laboratories

Abbott Labs Loves Merck More Than Gilead

Motley Fool

Mon, 07/19/10 - 06:46 pm

Abbott Laboratories

Gilead Sciences

Inverness Medical

Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra® ( lopinavir / ritonavir ) for Treatment-Experienced Patients

Vadvdert

Sat, 05/1/10 - 11:03 am

Abbott Laboratories

Mylan says WHO approves generic version of heat-resistant HIV drug Kaletra

Yahoo/AP

Wed, 02/25/09 - 10:33 am